Synthetic Type III-E CRISPR-Cas Effectors for Programmable RNA-targeting
Year: 2025
Type: article
Abstract: The recent discovery of the type III-E class of CRISPR-Cas effectors has reshaped our fundamental understanding of CRISPR-Cas evolution and classification. Type III-E effectors are composed of several Cas7-like domains and a single Cas11-like domain naturally fused together to create a single polypeptide capable of targeting and degrading RNA. Here we identified a novel type III-E-like effector composed of three Cas7 domains and a Cas1 domain which was not active but could be engineered into an active chimeric RNA-targeting Cas effector by domain additions and swaps from other type III-E effectors. The results reveal that various domains in type III-E effectors can be swapped for the equivalent domain from a different type III-E effector. Remarkably, the Cas1 domain located at the C-terminus of Cas7-1 could be swapped in place of the Cas11 domain located between the Cas7.1 and the Cas7.2 domains of DiCas7-11. The results reveal a new modality for engineering type III-E effectors from the blueprints found in nature.
Source: Journal of Molecular Biology
Institution: University of California San Diego
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,730
Awards: G1426609133, G2119791863, Transcriptome engineering technologies for the development of antiviral effectors in mosquitoes, Development of synthetic gene drives using small molecules, Development of synthetic viral circuitry to regulate viruses in mosquito disease vectors, G7249416017, G8690095842
OpenAlex ID: W4416746565
